Idaho. He is a Colonel in the U.S. Army Reserve and has been deployed three times to Iraq and Afghanistan, and has served as the U.S. Army Joint Theater Trauma System Director.

Dr. Schreiber completed medical school at Case Western Reserve University, and completed a residency and fellowship at the University of Washington.

EDWARD L. SNYDER, MD

Dr. Edward Snyder is an internationally known Transfusion Medicine expert, who has served on over 130 National Institutes of Health Study Section, Committee and SEP positions, many as Chair. Dr. Snyder has been a consultant and reviewer for the FDA. He is a past Board Chair of the National Marrow Donor Program and a past President of the American Association of Blood Banks. He was Chair of the American Society of Hematology Subcommittee oncenter.

Dr. Snyder receives extramural funding from the NHLBI as PI of the REDS-III contract, as well as extramural funding from industry as regards the Pathogen Reduction observational study alluded to above. He has received several R13 grants from NHLBI to conduct cutting-edge conferences on topics in Transfusion. He has published and presented over 350 publications, book chapters and abstracts.

DONAT R. SPAHN, MD

Professor and Chairman, Institute of Anesthesiology, University Hospital Zurich

Dr. Donat Spahn received his medical degree from the University of Zurich, Switzerland. This was followed by several clinical and research posts within Switzerland and the U.S. He spent three years as a Research Associate in the Department of Anesthesiology at Duke University Medical Center, Durham, NC. He previously spent six years as Professor and Chairman of the Department